Koers Ocean Biomedical, Inc. Nasdaq
Aandelen
OCEA
US67644P1057
Biotechnologie & Medisch Onderzoek
Omzet 2023 * | - | Omzet 2024 * | - | Marktkapitalisatie | 60,98 mln. 57,25 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 * | -92 mln. -86,36 mln. | Nettowinst (verlies) 2024 * | -32 mln. -30,04 mln. | EV/omzet 2023 * | - |
Nettoliquiditeiten 2023 * | - 0 | Nettoliquiditeiten 2024 * | - 0 | EV/omzet 2024 * | - |
K/w-verhouding 2023 * |
-0,57
x | K/w-verhouding 2024 * |
-1,98
x | Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 28,01% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,10% | 102 mld. | |
+2,11% | 96,07 mld. | |
-1,80% | 21,66 mld. | |
-17,75% | 20,77 mld. | |
-6,91% | 18,53 mld. | |
-42,00% | 16,91 mld. | |
-28,19% | 13,79 mld. | |
+0,18% | 13,33 mld. | |
+19,90% | 10,94 mld. |